COMMUNIQUÉS West-GlobeNewswire

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
16/08/2024
Highlights: $3.5 (USD $2.3) million funding for NMRC and WRAIR approved by the U.S. Department of Defense to advance the development of Travelan. MELBOURNE, Australia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ( [...]
Vistin Pharma ASA: Invitation to Q2 2024 conference call
16/08/2024
Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23 rd of August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties [...]
Aino Health AB (publ): interim report january-june 2024
16/08/2024
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Extending contracts. Improved cash flow. January – June 2024 • Net sales were KSEK 12 [...]
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2024 (UNAUDITED)
16/08/2024
Company announcement, Helsinki, August 16, 2024 at 9 am (EEST) NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2024 (UNAUDITED) NEXSTIM CONTINUED TO GROW AND IMPROVED ITS PROFITABILITY IN THE FIRST HALF OF THE YEAR [...]
Aptose Announces Adjournment of its Special Meeting of Shareholders
15/08/2024
SAN DIEGO and TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
15/08/2024
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same [...]
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
15/08/2024
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same [...]
Certara Launches Phoenix™ Version 8.5 Drug Development Software
15/08/2024
RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5. Phoenix is the pharmaceutical industry [...]
MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
15/08/2024
Approval Helps Solidify NexoBrid’s Position in the U.S. as a Safe and Effective Non-Surgical Burn Treatment for All Ages YAVNE, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader [...]
Codexis Publishes FY2023 Sustainability Disclosures
15/08/2024
Inaugural ESG Disclosures Align with the Sustainability Accounting Standards Board REDWOOD CITY, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today [...]
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
15/08/2024
Approval Expands NexoBrid Target Customer Base to Include Approximately 20 Pediatric Burn Centers CAMBRIDGE, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for [...]
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
15/08/2024
The combined company’s shares and warrants are expected to begin trading on Nasdaq under the tickers “SLXN” and “SLXNW”, respectively on August 16, 2024 MODI'IN, Israel and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- [...]
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
15/08/2024
DelOrefice is the Chief Financial Officer at BD, one of the largest global MedTech companies in the world Board appointment brings over 30 years of strategic and operational finance expertise SAN DIEGO, Aug. 15, 2024 ( [...]
NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process
15/08/2024
Company demonstrates reliable production from multiple biological sources These manufacturing advancements provide NurExone flexibility in optimizing its exosome production method, ensuring consistency while maintaining [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15/08/2024
BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1, 2024, Anika granted non [...]
Beacon Behavioral Partners Expands to Pennsylvania with Partnership of Nexus Group
15/08/2024
The network of physician-driven psychiatric practices develops beyond the Southeastern United States to further improve patient care BATON ROUGE, La., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners , a [...]
Canadian Red Cross announces additional financial assistance for people impacted by wildfires in Jasper, Alberta
15/08/2024
Additional $500 per household for Jasper residents will provide support for ongoing needs OTTAWA, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Starting today, the Canadian Red Cross is distributing an additional $500 in [...]
La Croix-Rouge canadienne annonce une aide financière additionnelle pour les personnes touchées par les feux de forêt à Jasper, en Alberta
15/08/2024
Un montant additionnel de 500 $ par ménage permettra aux résidents et résidentes de Jasper de répondre à leurs besoins OTTAWA, Ontario, 15 août 2024 (GLOBE NEWSWIRE) -- À compter d’aujourd’hui, la Croix-Rouge canadienne [...]
CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
15/08/2024
WARREN, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Tevogen Bio Inc (Nasdaq: TVGN), please note that paragraph two has been updated. The corrected release follows [...]

Pages